Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 7 · below the Ichimoku cloud · RSI 22 (oversold) · MACD below its signal · 1% above its 52-week low
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $1.2M | 0.00% | 230.00K | +11× | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CVRX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.5 | 19.1 | 15.9 | -20.6 | -25.7 | -7.9 | 0.7 | -42.8 | -40.9 | -22.3 | −80.8% | ||
| 2025 | 26.1 | -18.9 | -5.6 | -40.1 | -9.4 | -11.4 | 35.4 | -1.4 | 2.8 | 26.3 | -3.7 | -27.6 | −44.0% |
| 2024 | -20.1 | -21.9 | -7.2 | -14.8 | -55.2 | 72.5 | -28.7 | 15.3 | -10.6 | 48.9 | 16.8 | -17.3 | −59.7% |
| 2023 | -17.2 | -26.8 | -16.2 | 24.9 | 7.6 | 23.3 | 16.1 | -3.2 | -12.6 | -11.8 | 53.0 | 53.6 | +71.3% |
| 2022 | -32.1 | 5.8 | -31.8 | 4.0 | -0.3 | -3.2 | 46.9 | -17.9 | 28.7 | 8.0 | 32.7 | 37.1 | +50.0% |
| 2021 | -29.5 | -3.4 | -13.2 | 2.2 | -31.5 | 5.6 | −56.3% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Binkowski BrentChief Operating Officer | Purchase at price 2.91 per share. | 26.2K | $76.43K |
| Aug 11, 2026 | Binkowski BrentChief Operating Officer | Sale at price 2.55 per share. | 1.3K | $3.34K |
| May 31, 2026 | Slattery Joseph PDirector | Stock Award(Grant) at price 0.00 per share. | 8.7K | — |
| May 31, 2026 | Dale Michael DDirector | Stock Award(Grant) at price 0.00 per share. | 29K | — |
| May 31, 2026 | Hill Mitch CDirector | Stock Award(Grant) at price 0.00 per share. | 8.7K | — |
| May 31, 2026 | Ballinger Kevin JDirector | Stock Award(Grant) at price 0.00 per share. | 8.7K | — |
| May 31, 2026 | Jain Mudit KumarDirector | Stock Award(Grant) at price 0.00 per share. | 8.7K | — |
| May 31, 2026 | Nielsen Kirk GDirector | Stock Award(Grant) at price 0.00 per share. | 8.7K | — |
| May 31, 2026 | Shadan MarthaDirector | Stock Award(Grant) at price 0.00 per share. | 8.7K | — |
| Mar 1, 2026 | Hykes KevinChief Executive Officer | Sale at price 7.90 per share. | 7.8K | $61.35K |
| Mar 1, 2026 | Verrastro PaulOfficer | Sale at price 7.90 per share. | 1.3K | $10.15K |
| Mar 1, 2026 | Oasheim JaredChief Financial Officer | Sale at price 7.90 per share. | 1.7K | $13.78K |
| Mar 1, 2026 | John Robert AllenOfficer | Sale at price 7.90 per share. | 4K | $31.33K |
| Mar 1, 2026 | Adamson Philip B.Officer | Sale at price 7.90 per share. | 1.3K | $9.97K |
| Mar 1, 2026 | Morrison GregoryOfficer | Stock Award(Grant) at price 0.00 per share. | 34K | — |
| Feb 26, 2026 | Hykes KevinChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 159K | — |
| Feb 26, 2026 | Binkowski BrentChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 15K | — |
| Feb 26, 2026 | Verrastro PaulOfficer | Stock Award(Grant) at price 0.00 per share. | 45K | — |
| Feb 26, 2026 | Oasheim JaredChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 61K | — |
| Feb 26, 2026 | John Robert AllenOfficer | Stock Award(Grant) at price 0.00 per share. | 35K | — |
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Buy / hold / sell counts